Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Molecular Pain
Published in: Molecular Pain 1/2009

Open Access 01-12-2009 | Research

Proinflammatory-activated trigeminal satellite cells promote neuronal sensitization: relevance for migraine pathology

Authors: Alessandro Capuano, Alice De Corato, Lucia Lisi, Giuseppe Tringali, Pierluigi Navarra, Cinzia Dello Russo

Published in: Molecular Pain | Issue 1/2009

Login to get access

Abstract

Background

Migraine is a complex, chronic, painful, neurovascular disorder characterized by episodic activation of the trigeminal system. Increased levels of calcitonin gene-related peptide (CGRP) are found at different levels during migraine attacks. Interestingly, CGRP is also released within the trigeminal ganglia suggesting possible local effects on satellite cells, a specialized type of glia that ensheaths trigeminal neurons. CGRP was shown to enhance satellite-cell production of interleukin 1β (IL-1β), while trigeminal neurons express an activity-dependent production of nitric oxide (NO). Thus, in the present study we tested the hypothesis that IL-1β and NO induce trigeminal satellite cell activation, and that once activated these cells can influence neuronal responses.

Results

Primary cultures of rat trigeminal satellite cells isolated from neuronal cultures were characterized in vitro. Cyclooxygenase (COX) expression and activity were taken as a marker of glial pro-inflammatory activation. Most of the experiments were carried out to characterize satellite cell responses to the two different pro-inflammatory stimuli. Subsequently, medium harvested from activated satellite cells was used to test possible modulatory effects of glial factors on trigeminal neuronal activity. IL-1β and the NO donor diethylenetriamine/nitric oxide (DETA/NO) elevated PGE2 release by satellite cells. The stimulatory effect of IL-1β was mediated mainly by upregulation of the inducible form of COX enzyme (COX2), while NO increased the constitutive COX activity. Regardless of the activator used, it is relevant that short exposures of trigeminal satellite cells to both activators induced modifications within the cells which led to significant PGE2 production after removal of the pro-inflammatory stimuli. This effect allowed us to harvest medium from activated satellite cells (so-called 'conditioned medium') that did not contain any stimulus, and thus test the effects of glial factors on neuronal activation. Conditioned medium from satellite cells activated by either IL-1β or NO augmented the evoked release of CGRP by trigeminal neurons.

Conclusion

These findings indicate that satellite cells contribute to migraine-related neurochemical events and are induced to do so by autocrine/paracrine stimuli (such as IL-1β and NO). The responsiveness of IL-1β to CGRP creates the potential for a positive feedback loop and, thus, a plurality of targets for therapeutic intervention in migraine.
Appendix
Available only for authorised users
Literature
1.
Sanchez-Del-Rio M, Reuter U, Moskowitz MA: New insights into migraine pathophysiology. Curr Opin Neurol 2006, 19: 294–298. 10.1097/01.wco.0000227041.23694.5cPubMedCrossRef
2.
3.
Goadsby PJ, Fields HL: On the functional anatomy of migraine. Ann Neurol 1998, 43: 272. 10.1002/ana.410430221PubMedCrossRef
4.
Edvinsson L: Calcitonin gene-related peptide (CGRP) and the pathophysiology of headache: therapeutic implications. CNS Drugs 2001, 15: 745–753. 10.2165/00023210-200115100-00001PubMedCrossRef
5.
Sarchielli P, Alberti A, Codini M, Floridi A, Gallai V: Nitric oxide metabolites, prostaglandins and trigeminal vasoactive peptides in internal jugular vein blood during spontaneous migraine attacks. Cephalalgia 2000, 20: 907–918. 10.1046/j.1468-2982.2000.00146.xPubMedCrossRef
6.
Strassman AM, Levy D: Response properties of dural nociceptors in relation to headache. J Neurophysiol 2006, 95: 1298–1306. 10.1152/jn.01293.2005PubMedCrossRef
7.
Li J, Vause CV, Durham PL: Calcitonin gene-related peptide stimulation of nitric oxide synthesis and release from trigeminal ganglion glial cells. Brain Res 2008, 1196: 22–32. 10.1016/j.brainres.2007.12.028PubMedCentralPubMedCrossRef
8.
Zhang Z, Winborn CS, Marquez de Prado B, Russo AF: Sensitization of calcitonin gene-related peptide receptors by receptor activity-modifying protein-1 in the trigeminal ganglion. J Neurosci 2007, 27: 2693–2703. 10.1523/JNEUROSCI.4542-06.2007PubMedCrossRef
9.
Morris R, Southam E, Braid DJ, Garthwaite J: Nitric oxide may act as a messenger between dorsal root ganglion neurones and their satellite cells. Neurosci Lett 1992, 137: 29–32. 10.1016/0304-3940(92)90290-NPubMedCrossRef
10.
Thippeswamy T, Morris R: Evidence that nitric oxide-induced synthesis of cGMP occurs in a paracrine but not an autocrine fashion and that the site of its release can be regulated: studies in dorsal root ganglia in vivo and in vitro. Nitric Oxide 2001, 5: 105–115. 10.1006/niox.2001.0316PubMedCrossRef
11.
Thippeswamy T, Morris R: The roles of nitric oxide in dorsal root ganglion neurons. Ann NY Acad Sci 2002, 962: 103–110. 10.1111/j.1749-6632.2002.tb04060.xPubMedCrossRef
12.
Dublin P, Hanani M: Satellite glial cells in sensory ganglia: their possible contribution to inflammatory pain. Brain Behav Immun 2007, 21: 592–598. 10.1016/j.bbi.2006.11.011PubMedCrossRef
13.
Heblich F, England S, Docherty RJ: Indirect actions of bradykinin on neonatal rat dorsal root ganglion neurones: a role for non-neuronal cells as nociceptors. J Physiol 2001, 536: 111–121. 10.1111/j.1469-7793.2001.00111.xPubMedCentralPubMedCrossRef
14.
Thalakoti S, Patil VV, Damodaram S, Vause CV, Langford LE, Freeman SE, Durham PL: Neuron-glia signaling in trigeminal ganglion: implications for migraine pathology. Headache 2007, 47: 1008–1123. 10.1111/j.1526-4610.2007.00854.xPubMedCentralPubMedCrossRef
15.
Capuano A, Currò D, Dello Russo C, Tringali G, Pozzoli G, Di Trapani G, Navarra P: Nociceptin (1–13)NH2 inhibits stimulated calcitonin-gene-related-peptide release from primary cultures of rat trigeminal ganglia neurones. Cephalalgia 2007, 27: 868–876. 10.1111/j.1468-2982.2007.01354.xPubMedCrossRef
16.
Hanani M: Satellite glial cells in sensory ganglia: from form to function. Brain Res Brain Res Rev 2005, 48: 457–576. 10.1016/j.brainresrev.2004.09.001PubMedCrossRef
17.
Cherkas PS, Huang TY, Pannicke T, Tal M, Reichenbach A, Hanani M: The effects of axotomy on neurons and satellite glial cells in mouse trigeminal ganglion. Pain 2004, 110: 290–298. 10.1016/j.pain.2004.04.007PubMedCrossRef
18.
Takeda M, Tanimoto T, Kadoi J, Nasu M, Takahashi M, Kitagawa J, Matsumoto S: Enhanced excitability of nociceptive trigeminal ganglion neurons by satellite glial cytokine following peripheral inflammation. Pain 2007, 129: 155–166. 10.1016/j.pain.2006.10.007PubMedCrossRef
19.
Copray JC, Mantingh I, Brouwer N, Biber K, Küst BM, Liem RS, Huitinga I, Tilders FJ, Van Dam AM, Boddeke HW: Expression of interleukin-1 beta in rat dorsal root ganglia. J Neuroimmunol 2001, 118: 203–211. 10.1016/S0165-5728(01)00324-1PubMedCrossRef
20.
Ozaktay AC, Kallakuri S, Takebayashi T, Cavanaugh JM, Asik I, DeLeo JA, Weinstein JN: Effects of interleukin-1 beta, interleukin-6, and tumor necrosis factor on sensitivity of dorsal root ganglion and peripheral receptive fields in rats. Eur Spine J 2006, 15: 1529–1537. 10.1007/s00586-005-0058-8PubMedCrossRef
21.
Nicolson TA, Foster AF, Bevan S, Richards CD: Prostaglandin E2 sensitizes primary sensory neurons to histamine. Neuroscience 2007, 150: 22–30. 10.1016/j.neuroscience.2007.09.003PubMedCrossRef
22.
Zhang XC, Strassman AM, Burstein R, Levy D: Sensitization and activation of intracranial meningeal nociceptors by mast cell mediators. J Pharmacol Exp Ther 2007, 322: 806–812. 10.1124/jpet.107.123745PubMedCrossRef
23.
Lin CR, Amaya F, Barrett L, Wang H, Takada J, Samad TA, Woolf CJ: Prostaglandin E2 receptor EP4 contributes to inflammatory pain hypersensitivity. J Pharmacol Exp Ther 2006, 319: 1096–1103. 10.1124/jpet.106.105569PubMedCrossRef
24.
Ringwood L, Li L: The involvement of the interleukin-1 receptor-associated kinases (IRAKs) in cellular signaling networks controlling inflammation. Cytokine 2008, 42: 1–7. 10.1016/j.cyto.2007.12.012PubMedCentralPubMedCrossRef
25.
Tsatsanis C, Androulidaki A, Venihaki M, Margioris AN: Signalling networks regulating cyclooxygenase-2. Int J Biochem Cell Biol 2006, 38: 1654–1661. 10.1016/j.biocel.2006.03.021PubMedCrossRef
26.
Minghetti L: Cyclooxygenase-2 (COX-2) in inflammatory and degenerative brain diseases. J Neuropathol Exp Neurol 2004, 63: 901–910.PubMed
27.
Cao H, Zhang YQ: Spinal glial activation contributes to pathological pain states. Neurosci Biobehav Rev 2008, 32: 972–983. 10.1016/j.neubiorev.2008.03.009PubMedCrossRef
28.
Ren K, Dubner R: Neuron-glia crosstalk gets serious: role in pain hypersensitivity. Curr Opin Anaesthesiol 2008, 21: 570–579. 10.1097/ACO.0b013e32830edbdfPubMedCentralPubMedCrossRef
29.
Romero-Sandoval EA, Horvath RJ, DeLeo JA: Neuroimmune interactions and pain: focus on glial-modulating targets. Curr Opin Investig Drugs 2008, 9: 726–734.PubMedCentralPubMed
30.
Fukuoka H, Kawatani M, Hisamitsu T, Takeshige C: Cutaneous hyperalgesia induced by peripheral injection of interleukin-1 beta in the rat. Brain Res 1994, 657: 133–140. 10.1016/0006-8993(94)90960-1PubMedCrossRef
31.
Hou L, Li W, Wang X: Mechanism of interleukin-1 beta-induced calcitonin gene-relatedpeptide production from dorsal root ganglion neurons of neonatal rats. J Neurosci Res 2003,73(2):188–97. 10.1002/jnr.10651PubMedCrossRef
32.
Mizuno M, Kondo E, Nishimura M, Ueda Y, Yoshiya I, Tohyama M, Kiyama H: Localization of molecules involved in cytokine receptor signaling in the rat trigeminal ganglion. Brain Res Mol Brain Res 1997, 44: 163–166. 10.1016/S0169-328X(96)00283-5PubMedCrossRef
33.
Binshtok AM, Wang H, Zimmermann K, Amaya F, Vardeh D, Shi L, Brenner GJ, Ji RR, Bean BP, Woolf CJ, Samad TA: Nociceptors are interleukin-1beta sensors. J Neurosci 2008, 28: 14062–14073. doi:10.1523/JNEUROSCI.3795-08.2008PubMedCentralPubMedCrossRef
34.
Ohtori S, Takahashi K, Moriya H, Myers RR: TNF-alpha and TNF-alpha receptor type 1 upregulation in glia and neurons after peripheral nerve injury: studies in murine DRG and spinal cord. Spine 2004, 29: 1082–1088. 10.1097/00007632-200405150-00006PubMedCrossRef
35.
Schäfers M, Sorkin L: Effect of cytokines on neuronal excitability. Neurosci Lett 2008, 437: 188–93. 10.1016/j.neulet.2008.03.052PubMedCrossRef
36.
Cunha FQ, Ferreira SH: Peripheral hyperalgesic cytokines. Adv Exp Med Biol 2003, 521: 22–39.PubMed
37.
Thippeswamy T, McKay JS, Morris R, Quinn J, Wong LF, Murphy D: Glial-mediated neuroprotection: evidence for the protective role of the NO-cGMP pathway via neuron-glial communication in the peripheral nervous system. Glia 2005, 49: 197–210. 10.1002/glia.20105PubMedCrossRef
38.
Bauer MB, Murphy S, Gebhart GF: Stimulation of cyclic GMP production via a nitrosyl factor in sensory neuronal cultures by algesic or inflammatory agents. J Neurochem. 1995,65(1):363–372. 10.1046/j.1471-4159.1995.65010363.xPubMedCrossRef
39.
Kummer W, Behrends S, Schwarzlmüller T, Fischer A, Koesling D: Subunits of soluble guanylyl cyclase in rat and guinea-pig sensory ganglia. Brain Res 1996, 721: 191–195. 10.1016/0006-8993(96)00097-2PubMedCrossRef
40.
Magnusson S, Alm P, Kanje M: CGMP increases in satellite cells of nitric oxide synthase-containing sensory ganglia. NeuroReport 2000, 11: 3389–3395. 10.1097/00001756-200010200-00025PubMedCrossRef
41.
Bellamy J, Bowen EJ, Russo AF, Durham PL: Nitric oxide regulation of calcitonin gene-related peptide gene expression in rat trigeminal ganglia neurons. Eur J Neurosci 2006, 23: 2057–2066. 10.1111/j.1460-9568.2006.04742.xPubMedCentralPubMedCrossRef
42.
Freeman SE, Patil VV, Durham PL: Nitric oxide-proton stimulation of trigeminal ganglion neurons increases mitogen-activated protein kinase and phosphatase expression in neurons and satellite glial cells. Neuroscience 2008, 157: 542–555. 10.1016/j.neuroscience.2008.09.035PubMedCentralPubMedCrossRef
43.
Neeb L, Reuter U: Nitric oxide in migraine. CNS Neurol Disord Drug Targets 2007, 6: 258–264. 10.2174/187152707781387233PubMedCrossRef
44.
Mollace V, Muscoli C, Masini E, Cuzzocrea S, Salvemini D: Modulation of prostaglandin biosynthesis by nitric oxide and nitric oxide donors. Pharmacol Rev 2005, 57: 217–252. 10.1124/pr.57.2.1PubMedCrossRef
45.
Persichini T, Cantoni O, Suzuki H, Colasanti M: Cross-talk between constitutive and inducible NO synthase: an update. Antioxid Redox Signal 2006, 8: 949–954. 10.1089/ars.2006.8.949PubMedCrossRef
46.
Tringali G, Pozzoli G, Vairano M, Mores N, Preziosi P, Navarra P: Interleukin-18 displays effects opposite to those of interleukin-1 in the regulation of neuroendocrine stress axis. J Neuroimmunol 2005, 160: 61–67. 10.1016/j.jneuroim.2004.10.028PubMedCrossRef
47.
Livak KJ, Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 2001, 25: 402–408. 10.1006/meth.2001.1262PubMedCrossRef
48.
Dello Russo C, Lisi L, Tringali G, Navarra P: Involvement of mTOR kinase in cytokine dependent microglial activation and cell proliferation. Biochem Pharmacol 2009, in press.
Metadata
Title
Proinflammatory-activated trigeminal satellite cells promote neuronal sensitization: relevance for migraine pathology
Authors
Alessandro Capuano
Alice De Corato
Lucia Lisi
Giuseppe Tringali
Pierluigi Navarra
Cinzia Dello Russo
Publication date
01-12-2009
Publisher
BioMed Central
Published in
Molecular Pain / Issue 1/2009
Electronic ISSN: 1744-8069
DOI
https://doi.org/10.1186/1744-8069-5-43

Other articles of this Issue 1/2009

Molecular Pain 1/2009 Go to the issue

Methodology

Mice with cisplatin and oxaliplatin-induced painful neuropathy develop distinct early responses to thermal stimuli

Research

Signal Transduction Mechanisms Underlying Group I mGluR-mediated Increase in Frequency and Amplitude of Spontaneous EPSCs in the Spinal Trigeminal Subnucleus Oralis of the Rat

Research

Reactive oxygen species mediate TNFR1 increase after TRPV1 activation in mouse DRG neurons

Research

The endogenous hydrogen sulfide producing enzyme cystathionine-β synthase contributes to visceral hypersensitivity in a rat model of irritable bowel syndrome

Research

Morphine modulation of pain processing in medial and lateral pain pathways

Research

Upregulation of casein kinase 1ε in dorsal root ganglia and spinal cord after mouse spinal nerve injury contributes to neuropathic pain